Visceral leishmaniasis in Malta---an 18 year paediatric, population based study
Open Access
- 1 May 2000
- journal article
- research article
- Published by BMJ in Archives of Disease in Childhood
- Vol. 82 (5) , 381-385
- https://doi.org/10.1136/adc.82.5.381
Abstract
BACKGROUND Visceral leishmaniasis (VL) is a chronic parasitic infection that infects approximately 400 000 individuals annually, with a predilection towards early childhood. AIMS To study the epidemiology of VL in childhood. METHODS VL is endemic in Malta, a small archipelago of islands in the centre of the Mediterranean with a total population approaching half a million. Notification of human cases of leishmaniasis is compulsory. Case records of all 81 paediatric patients with VL between 1980 and 1998 were analysed. RESULTS The annual incidence of VL declined for all cases of VL, and declined significantly for paediatric cases (p = 0.01). For 1994 to 1998, the overall incidence of VL was 0.9 per 100 000 total population and the paediatric incidence was 2.5 per 100 000 population. Median age at presentation was 34 months. Common features at presentation were splenomegaly, hepatomegaly, fever, and pancytopenia with high lymphocyte and monocyte counts. The diagnostic sensitivity of isolated immunofluorescent antibody testing was equivalent to bone marrow aspiration (95%). Blood transfusions for anaemia were required in 93% of patients. Eleven per cent had intercurrent infections. All patients were cured, and were initially treated with intravenous sodium stibogluconate. Defervescence occurred after a median of six days of treatment, and patients continued to be treated on a day case basis. Nine relapsers were retreated with sodium stibogluconate, achieving a cure rate of 94%, but five patients required additional drug therapy. There were no permanent sequelae associated with VL or its treatment. CONCLUSIONS The decreased incidence is attributed to the eradication of stray dogs which are the disease reservoir.Keywords
This publication has 17 references indexed in Scilit:
- Trial of oral miltefosine for visceral leishmaniasisThe Lancet, 1998
- Pediatric visceral leishmaniasis in southern FranceThe Pediatric Infectious Disease Journal, 1998
- Randomised controlled trial of aminosidine (paromomycin) v sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India Commentary: Some good news for treatment of visceral leishmaniasis in BiharBMJ, 1998
- TheLeishmaniapromastigote surface antigen-2 (PSA-2) is specifically recognised by Th1 cells in humans with naturally acquired immunity toL. majorFEMS Immunology & Medical Microbiology, 1998
- Leishmaniasis in Malta and the Mediterranean BasinPathogens and Global Health, 1997
- Aminosidine plus sodium stibogluconate for the treatment of Indian kala-azar: a randomized dose-finding clinical trialTransactions of the Royal Society of Tropical Medicine and Hygiene, 1995
- Visceral leishmaniasis and HIV-1 co-infection in southern FranceTransactions of the Royal Society of Tropical Medicine and Hygiene, 1995
- Relationship between direct agglutination test and splenic aspirate smear parasite load in visceral leishmaniasis at Baringo District, Kenya.1994
- Visceral leishmaniasis in a child with HIV-1 infectionEuropean Journal of Pediatrics, 1994
- The recognition and estimation of cyclic trendsAnnals of Human Genetics, 1961